BioCryst Pharmaceuticals BCRX Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's preferred stock, shares outstanding.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's preferred stock, shares outstanding?
- BioCryst Pharmaceuticals (BCRX) reported preferred stock, shares outstanding of $0 in Q1 2026.